BackEikon Therapeutics Common Stock Overview

Eikon Therapeutics Common Stock Total Current Liabilities

Track Eikon Therapeutics Common Stock's total current liabilities ($45M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$45.06M

Peer average

Loading

Eikon Therapeutics Common Stock Total Current Liabilities History

Loading

Eikon Therapeutics Common Stock vs. peers: Total Current Liabilities Comparison

Loading

Eikon Therapeutics Common Stock Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Eikon Therapeutics Common Stock (EIKN) FAQ

Eikon Therapeutics Common Stock (EIKN) currently reports a total current liabilities of $45M as of March 2026. Use the charts on this page to explore Eikon Therapeutics Common Stock's total current liabilities history and peer comparisons.

Eikon Therapeutics Common Stock reported $45M in total current liabilities as of March 2026. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $45M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Eikon Therapeutics Common Stock, and consider following EIKN for alerts when major investors trade the stock.

Eikon Therapeutics Common Stock is classified in the Healthcare sector. On total current liabilities, it currently shows $45M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing EIKN with unrelated industries.